# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-21-003140
Filing Date
2021-03-04
Accepted
2021-03-03 19:48:19
Documents
110
Period of Report
2020-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | txmd-10k_123120.htm iXBRL | 10-K | 2066661
2 | SECOND AMENDMENT TO COMPANY WARRANT | ex10-12.htm | EX-10.12 | 17720
3 | WARRANT ISSUED TO ROBERT G. FINIZIO | ex10-13.htm | EX-10.13 | 4883
4 | AMENDMENT TO WARRANT ISSUED TO ROBERT G. FINIZIO | ex10-14.htm | EX-10.14 | 10132
5 | WARRANT ISSUED TO JOHN C.K. MILLIGAN, IV | ex10-15.htm | EX-10.15 | 4457
6 | AMENDMENT TO WARRANT ISSUED TO JOHN C.K. MILLIGAN, IV | ex10-16.htm | EX-10.16 | 6624
7 | AMENDMENT NO. 7 TO THE FINANCING AGREEMENT | ex10-24.htm | EX-10.24 | 62557
8 | AMENDMENT NO. 8 TO THE FINANCING AGREEMENT | ex10-25.htm | EX-10.25 | 90970
9 | EMPLOYMENT AGREEMENT WITH EDWARD J. BORKOWSKI | ex10-41.htm | EX-10.41 | 102036
10 | AMENDMENT TO EMPLOYMENT AGREEMENT WITH EDWARD J. BORKOWSKI | ex10-42.htm | EX-10.42 | 7387
11 | CONSENT OF GRANT THORNTON LLP | ex23-1.htm | EX-23.1 | 3807
12 | CERTIFICATION OF CHIEF EXECUTIVE OFFICER | ex31-1.htm | EX-31.1 | 11609
13 | CERTIFICATION OF CHIEF FINANCIAL OFFICER | ex31-2.htm | EX-31.2 | 11657
14 | CERTIFICATION OF CHIEF EXECUTIVE OFFICER | ex32-1.htm | EX-32.1 | 7738
15 | CERTIFICATION OF CHIEF FINANCIAL OFFICER | ex32-2.htm | EX-32.2 | 7769
21 | GRAPHIC | ex10-13_img01.gif | GRAPHIC | 248007
22 | GRAPHIC | ex10-13_img03.gif | GRAPHIC | 301947
23 | GRAPHIC | ex10-13_img05.gif | GRAPHIC | 292344
24 | GRAPHIC | ex10-13_img07.gif | GRAPHIC | 70254
25 | GRAPHIC | ex10-13_img09.gif | GRAPHIC | 52983
26 | GRAPHIC | ex10-13_img11.gif | GRAPHIC | 35965
27 | GRAPHIC | ex10-15_img01.gif | GRAPHIC | 247046
28 | GRAPHIC | ex10-15_img02.gif | GRAPHIC | 301719
29 | GRAPHIC | ex10-15_img03.gif | GRAPHIC | 294231
30 | GRAPHIC | ex10-15_img04.gif | GRAPHIC | 25059
31 | GRAPHIC | ex10-15_img05.gif | GRAPHIC | 20158
32 | GRAPHIC | ex10-15_img06.gif | GRAPHIC | 13741
33 | GRAPHIC | txmd10k001.jpg | GRAPHIC | 33383
34 | GRAPHIC | txmd10k002.jpg | GRAPHIC | 51471
35 | GRAPHIC | logo_img001.jpg | GRAPHIC | 3942
| Complete submission text file | 0001387131-21-003140.txt |  | 12154430

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
16 | XBRL SCHEMA FILE | txmd-20201231.xsd | EX-101.SCH | 75823
17 | XBRL CALCULATION FILE | txmd-20201231_cal.xml | EX-101.CAL | 82371
18 | XBRL DEFINITION FILE | txmd-20201231_def.xml | EX-101.DEF | 294335
19 | XBRL LABEL FILE | txmd-20201231_lab.xml | EX-101.LAB | 588560
20 | XBRL PRESENTATION FILE | txmd-20201231_pre.xml | EX-101.PRE | 439079
36 | EXTRACTED XBRL INSTANCE DOCUMENT | txmd-10k_123120_htm.xml | XML | 1214699

Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-00100 | Film No.: 21711765
SIC: 2834 Pharmaceutical Preparations